Lotte Biologics Accelerates Global CDMO Expansion Across North America and Asia
Seoul, South Korea Lotte Biologics is making significant strides in expanding its global presence in the Contract Development and Manufacturing […]
News
Azenta and Frenova Partner to Accelerate Genomic Research in Nephrology Through MyReason® Program
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced
Zenara Pharma Receives FDA Approval for First Generic Sertraline Hydrochloride Capsules with 180-Day Marketing Exclusivity
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)
Silexion Reports Breakthrough Preclinical Results, Showing Up to 97% Inhibition in KRAS-Driven Cancer Cells
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding new preclinical data
Genvira, Labskin, and NRC Launch Joint Canada-UK Initiative to Advance Melanoma Immunotherapies
Canada and the UK have joined forces in a groundbreaking project aimed at developing next-generation immunotherapies for malignant melanoma, a
News
Xenetic Biosciences and Periness Enter Clinical Study Agreement to Advance DNase 1 Platform for Large B-Cell Lymphoma Treatment
Xenetic Biosciences, Inc., a biopharmaceutical company pioneering in immuno-oncology, has entered into a clinical study agreement with Periness Ltd. to
W Health Ventures Launches $70 Million Fund to Fuel Healthcare Innovation in India
W Health Ventures has unveiled its second fund worth $70 million to support the development of healthcare startups in India,
Moderna’s Updated COVID-19 Vaccine Receives European Commission Approval for SARS-CoV-2 Variant LP.8.1
In a significant step toward bolstering public health preparedness, Moderna Inc. has received commercial authorization from the European Commission (EC)
Alafair Biosciences Secures FDA 510(k) Clearance for Versacoat™ Flowable Hydrogel Nerve and Tendon Protector
Alafair Biosciences, a leading innovator in medical device solutions for soft-tissue protection in orthopedic surgery, has received FDA 510(k) clearance
Kedrion Biopharma’s COAGADEX® Receives FDA Orphan Drug Designation for Acquired Factor X Deficiency (AFXD)
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the